Published in Health Business Week, June 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Laboratory Corporation of America.
Report 1: Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), an industry leader in prenatal clinical laboratory testing, announced today that it has entered into an agreement with U.K. based Intema Ltd. to license its technology for combining first- and second-trimester Down syndrome screening test results to assess the risk of Down syndrome. Terms of the agreement were not disclosed.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.